The haemato-oncologist from HCG Cancer Centre, Nashik, discusses how newer therapies are reshaping treatment decisions in aggressive lymphomas. The management of B-cell lymphoma has entered a phase where standard chemotherapy alone is no longer sufficient for a growing subset of patients. In routine oncology practice, clinicians are increasingly confronted with cases that either fail to … Continue reading When Standard Chemotherapy Is No Longer Enough in B-Cell Lymphoma, Says Dr. Priyatesh Dwivedi